Literature DB >> 28769159

DOSE RESPONSE RELATIONSHIP OF NEUROMUSCULAR BLOCKADE, INTUBATION CONDITIONS AND CARDIOVASCULAR CHANGES WITH CHANDONIUM IODIDE.

Y V Suri1, P C Tripathi2, R C Srimal3, Sps Gaur4, B N Dhawan5.   

Abstract

One hundred and forty ASA physical status I and II patients undergoing general or gynaecological surgery were the subjects of this study. Patients were randomly assigned into five groups receiving 100, 150, 180, 200 and 250 µg/kg I.V. of chandonium iodide after induction of general anaesthesia with thiopentone. Neuromuscular blockade was assessed clinically, as well as, with twitch response/train of four using myotest nerve stimulator. Increasing dosage of chandonium iodide decreased the time to onset of jaw relaxation and apnoea (p<0.01) and caused linear increase in the duration of neuromuscular blockade from 10.90 ± 5.31 to 25.18 ± 7.15 min (p<0.01) over the dosage rage of 100 to 250 µg/kg. Intubation conditions also improved with increasing doses of chandonium iodide, so that, although intubation was possible in all the patients, grading of good intubation conditions were achieved in 64, 80, 88, 100 and 100% of patients in groups I to V respectively. 200 µg/kg of chandonium iodide produced ideal intubation conditions. Recovery to spontaneous ventilation was rapid and smooth, further facilitated with neuromuscular antagonists. Short lasting increase in heart rate and blood pressure was seen which was neither dose dependent nor outlasting the duration of neuromuscular blockade.

Entities:  

Keywords:  Chandonium iodide; Intubation conditions; Neuromuscular blocking agents

Year:  2017        PMID: 28769159      PMCID: PMC5529698          DOI: 10.1016/S0377-1237(17)31036-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  6 in total

1.  Does clinical anesthesia need new neuromuscular blocking agents?

Authors:  J J Savarese; R J Kitz
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

2.  Persistent bradycardia with episodic sinus arrest after sufentanil and vecuronium administration--successful treatment with isoproterenol.

Authors:  W T Schmeling; J S Bernstein; E J Vucins; R Cody
Journal:  J Cardiothorac Anesth       Date:  1990-02

3.  Cardiovascular effects of pancuronium in man.

Authors:  G R Kelman; B R Kennedy
Journal:  Br J Anaesth       Date:  1971-04       Impact factor: 9.166

4.  A clinical comparison of pancuronium with d-tubocurarine.

Authors:  S A McDowell; R S Clarke
Journal:  Anaesthesia       Date:  1969-10       Impact factor: 6.955

5.  Bradycardia in patients receiving atracurium or vecuronium in conditions of low vagal stimulation.

Authors:  D A Cozanitis; L Lindgren; P H Rosenberg
Journal:  Anaesthesia       Date:  1989-04       Impact factor: 6.955

6.  Steroids and related studies. XXV. Chandonium iodide (17a-methyl-3beta-pyrrolidino-17a-aza-D-homoandrost-5-ene dimethiodide) and other quaternary ammonium steroid analogues.

Authors:  H Singh; D Paul
Journal:  J Chem Soc Perkin 1       Date:  1974
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.